The definition of a Part D rebatable drug includes drugs approved under a new drug application under section 505(c) of the Federal Food, Drug, and Cosmetic (FD&C) Act (that is, brand name drugs), generic drugs approved under section 505(j) of the FD&C Act that meet certain statutory criteria (that is, sole source generic drugs), and biologicals licensed under section 351 of the Public Health Service Act (PHS), including biosimilars
These pouches offer a promising path towards a smokeless, healthier lifestyle
1 2 3 Negcio da Costa da Mina e comrcio atlntico: tabaco, acar, ouro e trfico de escravos, Pernambuco (1654-1760) (Doutorado em Histria Econmica thesis) (in Portuguese)
We estimated that $517 million would be redistributed based on the budget neutrality requirement in the baseline model
As described in the CY 2022 PFS final rule (86 FR 65507 through 65509), we finalized the policy at 414.1380(b)(2)(v)(A) to provide scoring flexibility in instances where changes during a performance period impede the effective measurement of cost
